Related Experiment Video

Updated: Jul 29, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

940

Diagnosis and Treatment of Fungal Infections in Lung Transplant Recipients

Jesus E Escamilla1, Spenser E January1, Rodrigo Vazquez Guillamet2,3

  • 1Department of Pharmacy, Barnes-Jewish Hospital, Saint Louis, MO 63110, USA.

Pathogens (Basel, Switzerland)
|May 27, 2023
PubMed

Insights

Fungal infections pose a significant threat to lung transplant recipients, causing allograft damage and chronic lung allograft dysfunction. Early diagnosis and targeted antifungal treatments are crucial for improving patient outcomes.

Area of Science:

  • Infectious Diseases
  • Transplantation Medicine
  • Mycology

Background:

  • Fungal infections are a major cause of morbidity in lung transplant recipients.
  • These infections can lead to direct allograft damage and chronic lung allograft dysfunction.
  • Timely diagnosis and treatment are critical to prevent allograft loss.

Purpose of the Study:

  • To review the incidence, risk factors, and symptoms of fungal infections in lung transplant recipients.
  • To focus on diagnostic and treatment strategies for specific fungal pathogens.
  • To discuss evidence for newer antifungal agents in this population.

Main Methods:

  • Literature review of fungal infections in lung transplant recipients.
  • Focused analysis of diagnostic and treatment modalities.
  • Evaluation of emerging antifungal therapies.

Main Results:

  • Identified key fungal pathogens including Aspergillus, Candida, and Pneumocystis jirovecii.
  • Detailed diagnostic approaches and treatment guidelines for each pathogen.
  • Highlighted the role of newer triazoles and inhaled antifungals.

Conclusions:

  • Fungal infections significantly impact lung transplant outcomes.
  • Comprehensive diagnostic and treatment strategies are essential.
  • Emerging antifungal therapies offer new hope for managing these infections.
Keywords:
antifungalsfungal infectionslung transplant

More Related Videos

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

392
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

10.6K

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
203
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
293
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
219
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
41
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
182
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
222